Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Coronavirus disease	7/232	1.643426535473039e-09	1.429781085861544e-07	81.33481481481482	-256.4671362977982	C3;DDX58;IFNA1;IL1B;TLR4;TNF;VWF
KEGG_2021_Human	Legionellosis	4/57	4.533460591014752e-07	1.8726468862171252e-05	100.81761006289308	-216.95395722754864	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Necroptosis	5/159	6.457403055921121e-07	1.8726468862171252e-05	51.38961038961039	-155.93286055355003	HMGB1;IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Influenza A	5/172	9.546833775920581e-07	1.9073849033678265e-05	47.31137724550898	-145.44295329077605	DDX58;IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Tuberculosis	5/180	1.1964633404245137e-06	1.9073849033678265e-05	45.10285714285714	-139.64032975632463	C3;IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Leishmaniasis	4/77	1.5346775084568718e-06	1.9073849033678265e-05	73.01369863013699	-170.21630123625883	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Pertussis	4/76	1.4558243895816926e-06	1.9073849033678265e-05	74.03703703703704	-172.05130589538587	C3;IL1B;TLR4;TNF
KEGG_2021_Human	NF-kappa B signaling pathway	4/104	5.130876847568527e-06	4.463862857384618e-05	53.12	-132.3420645012429	DDX58;IL1B;TLR4;TNF
KEGG_2021_Human	Chagas disease	4/102	4.7476288106462685e-06	4.463862857384618e-05	54.21768707482993	-134.5540755438832	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	4/104	5.130876847568527e-06	4.463862857384618e-05	53.12	-132.3420645012429	IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Measles	4/139	1.6271599911932136e-05	0.0001286935629398269	39.175308641975306	-102.69295126036515	DDX58;IFNA1;IL1B;TLR4
KEGG_2021_Human	Malaria	3/50	2.5974439121209737e-05	0.0001883146836287706	73.13981762917933	-125.1475077148889	IL1B;TLR4;TNF
KEGG_2021_Human	Hepatitis B	4/162	2.979383554686203e-05	0.00019938951481361512	33.37552742616034	-89.36652156273904	DDX58;IFNA1;TLR4;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	4/181	4.608088790455273e-05	0.0002863598034068634	29.721280602636536	-80.60331713278154	IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.0002933550787767664	55.34101382488479	-100.98537671170521	IL1B;TLR4;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	3/63	5.21817057256637e-05	0.0002933550787767664	57.2	-103.63746645388204	DDX58;IFNA1;IL1B
KEGG_2021_Human	Neutrophil extracellular trap formation	4/189	5.45978286778746e-05	0.0002933550787767664	28.407207207207207	-77.37506956258395	C3;HMGB1;TLR4;VWF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	3/70	7.160249860764975e-05	0.00034607874327030716	51.17910447761194	-94.92366080084827	DDX58;IFNA1;TNF
KEGG_2021_Human	Lipid and atherosclerosis	4/215	9.035438443106581e-05	0.00041372797081593287	24.824644549763033	-68.34725873383007	IFNA1;IL1B;TLR4;TNF
KEGG_2021_Human	Complement and coagulation cascades	3/85	0.00012793645194335274	0.0005565235659535844	41.73867595818815	-80.46318508481777	C3;CFH;VWF
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.0006318726084313359	21.55922865013774	-59.801482853342776	C3;IL1B;TLR4;TNF
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.00016720908178540931	0.0006419917133045423	37.99047619047619	-74.4091590745228	IL1B;TLR4;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	5/498	0.00016972194719545373	0.0006419917133045423	15.365111561866126	-50.06173980977876	C3;DDX58;IFNA1;IL1B;TNF
KEGG_2021_Human	Amoebiasis	3/102	0.00021994493140062025	0.0007973003763272485	34.497835497835496	-68.58379435140506	IL1B;TLR4;TNF
KEGG_2021_Human	Yersinia infection	3/137	0.0005248515914701949	0.0018264835383162783	25.375266524520256	-52.38188378130509	IL1B;TLR4;TNF
KEGG_2021_Human	Hepatitis C	3/157	0.0007818177127513567	0.002616082346514155	22.024118738404454	-46.00245527612638	DDX58;IFNA1;TNF
KEGG_2021_Human	African trypanosomiasis	2/37	0.0008976760152685225	0.002892511604754128	57.378571428571426	-64.24352876962546	IL1B;TNF
KEGG_2021_Human	Graft-versus-host disease	2/42	0.0011566808072543669	0.0035939725082546397	50.175	-57.95352918467438	IL1B;TNF
KEGG_2021_Human	Type I diabetes mellitus	2/43	0.0012123028259538784	0.003636908477861635	48.94512195121951	-56.84526782917664	IL1B;TNF
KEGG_2021_Human	Pathogenic Escherichia coli infection	3/197	0.0015104299457678824	0.004380246842726859	17.394698085419734	-36.72187076283526	IL1B;TLR4;TNF
KEGG_2021_Human	Epstein-Barr virus infection	3/202	0.0016236545858167558	0.004556708031163153	16.946877243359655	-35.79178563433967	DDX58;IFNA1;TNF
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.005073025510543837	16.115516062884485	-34.04865723073064	IFNA1;TLR4;TNF
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.005835602702948501	15.146718146718147	-31.989452913184095	IFNA1;IL1B;TNF
KEGG_2021_Human	Salmonella infection	3/249	0.0029568377027043165	0.007566025886331633	13.627177700348431	-28.69609856443984	IL1B;TLR4;TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.011879125301562182	11.412915851272016	-23.74866982495136	IFNA1;IL1B;TNF
KEGG_2021_Human	Staphylococcus aureus infection	2/95	0.005791844483948442	0.01361866135414904	21.438172043010752	-28.45964210186145	C3;CFH
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.005673660825135872	0.01361866135414904	21.67391304347826	-28.742216935482162	IL1B;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.014276428326234285	20.331632653061224	-27.120602948412195	IL1B;TNF
KEGG_2021_Human	Hematopoietic cell lineage	2/99	0.006275930773922806	0.014276428326234285	20.54381443298969	-27.37901341152302	IL1B;TNF
KEGG_2021_Human	Human papillomavirus infection	3/331	0.006599251035795172	0.0143533710028545	10.113240418118467	-20.757683091358754	IFNA1;TNF;VWF
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.014655042689035764	19.524509803921568	-26.130280011490946	IL1B;TNF
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.015764906687429782	18.086363636363636	-24.33571316400054	TLR4;TNF
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.015764906687429782	9.422466422466423	-19.140881053489387	IFNA1;TLR4;VWF
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.015764906687429782	18.086363636363636	-24.33571316400054	IL1B;TNF
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.01964522701486296	15.886	-21.510038502238015	IL1B;TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.020398738116103026	15.385658914728682	-20.853034219946885	IFNA1;TNF
KEGG_2021_Human	Systemic lupus erythematosus	2/135	0.011426598240460687	0.02115136270042723	14.915413533834586	-20.230385574789178	C3;TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.02190288998228103	14.472627737226277	-19.639406588988233	IL1B;TNF
KEGG_2021_Human	Phagosome	2/152	0.014335605230985022	0.025453013369299938	13.196666666666667	-17.909946150058477	C3;TLR4
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.025890201333617323	12.933006535947712	-17.54750234216727	IL1B;TNF
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.038425972275744576	10.31020942408377	-13.840129933766221	C3;IFNA1
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.042195823576374074	9.685960591133005	-12.928804077098514	TLR4;TNF
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.061951422806692566	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	Base excision repair	1/33	0.040130782413471976	0.06465514944392707	27.90277777777778	-15.299431750604054	HMGB1
KEGG_2021_Human	Prion disease	2/273	0.04281158988095726	0.0677201512662415	7.192804428044281	-9.169844698845731	IL1B;TNF
KEGG_2021_Human	Allograft rejection	1/38	0.046083072411820386	0.07159334463979239	24.117117117117118	-13.560364723090352	TNF
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.07475740491330331	6.657534246575342	-8.337786615237395	IL1B;TNF
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.0833064971819476	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Autoimmune thyroid disease	1/53	0.06374115884515756	0.09399120033099506	17.128205128205128	-10.081098986019231	IFNA1
KEGG_2021_Human	Alzheimer disease	2/369	0.07347088540357372	0.10653278383518187	5.2459128065395095	-6.1057863985118	IL1B;TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.11541770810262304	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.11541770810262304	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.12776365902788028	11.531024531024531	-6.958150954500108	TNF
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.13978893487885866	9.961298377028713	-6.010407578745034	TNF
KEGG_2021_Human	ECM-receptor interaction	1/88	0.10380474953181053	0.13978893487885866	10.192848020434228	-6.152535327455873	VWF
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.13978893487885866	10.075757575757576	-6.080768259179883	TLR4
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.1428844510508667	4.014270613107822	-4.131104230952899	IL1B;TNF
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.1428844510508667	9.528076463560334	-5.7422174156532195	TNF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.1428844510508667	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.1428844510508667	9.130584192439862	-5.49346810373269	IL1B
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.14358845638252987	8.94388327721661	-5.375723879218761	TNF
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.14693353077880336	8.592233009708737	-5.152341092635986	TNF
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.1474309433131701	8.189300411522634	-4.893732148578802	TLR4
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.1474309433131701	8.345911949685535	-4.994589105830365	IL1B
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.1474309433131701	8.2668743509865	-4.943743954376122	TNF
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.15796665993366038	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Platelet activation	1/124	0.14339691916847833	0.16201989568386513	7.177055103884372	-4.231046804704064	VWF
KEGG_2021_Human	Autophagy	1/137	0.15730251033809037	0.17545279999248542	6.480392156862745	-3.763669230249352	HMGB1
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.17906195156330282	6.2466509062253746	-3.6047270952512624	TNF
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.19050837089018796	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.19706507356696398	5.456866804692892	-3.0596637281364782	IFNA1
KEGG_2021_Human	Focal adhesion	1/201	0.22284403856827387	0.2356506521850722	4.371111111111111	-2.2907190203417165	VWF
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.2356506521850722	4.326732673267327	-2.2588473265567357	C3
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.24901837036095406	4.001019367991845	-2.0240281738454993	TNF
KEGG_2021_Human	Neuroactive ligand-receptor interaction	1/341	0.3504975915199974	0.35874459367340905	2.5254901960784313	-0.9533164047874388	C3
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3738574373677736	2.3584328129782675	-0.8341701676241932	TNF
KEGG_2021_Human	Pathways in cancer	1/531	0.4935522426966286	0.4935522426966286	1.580293501048218	-0.3089273055464	IFNA1
